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We report here a de novo 16q24.1 interstitial duplication in a woman with a severe phenotype consistent with 
mental retardation, spastic paraplegia, severe epilepsy, a narrow and arched palate, malar hypoplasia, little 
subcutaneous fat and arachnodactyly. Although conventional karyotyping was found to be normal, array-CGH 
detected a small duplication on chromosome 16. Using QFM-PCR, we characterised its proximal and distal 
breakpoints. The duplication, which is approximately 250 kb, encompasses seven genes (KIAA0182, GINS2, 
c16orf74, COX4NB, COX4I1, MIR1910 and IRF8). Several reports have previously described large 16q 
duplications, and some of these overlap with our region in 16q24.1.  
Due to the variability of the described phenotypes, the characterisation of small 16q duplications may help to 
determine critical regions and the genes they contain that are associated with the components of complex 
phenotypes.  
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Introduction 
 Chromosomal abnormalities are a major cause of mental retardation. Unbalanced karyotypes are 
estimated to be present in 10 to 16 % of children with intellectual disabilities with or without dysmorphic signs 
and malformations [1, 2]. The recent application of molecular karyotyping in genomic medicine has strongly 
improved the detection of small chromosomal defects and has revealed new information about regions that are 
potentially involved in intellectual disabilities [3]. Although complete trisomies of chromosome 16 are 
associated with spontaneous abortions, partial duplications of 16q have been associated with different 
phenotypes such as mental retardation, dysmorphic features and limited post-natal survival [4]. 
Here, we report a woman with a small de novo duplication of 250 kb in the 16q24.1 region detected by 
chromosomal microarray and confirmed by quantitative fluorescence multiplex-PCR (QFM-PCR). Because our 
patient’s clinical features are particularly severe considering the size of the duplication, we compared her 
phenotype with previously described cases of 16q trisomy [4-13]. Small chromosomal rearrangements such as 
the one found in this case may help to delineate the contribution of selected genes in larger 16q duplications.  
Clinical report 
Case report 
The patient is a 26-year-old woman born to non-consanguineous and unaffected parents after an 
uncomplicated pregnancy. She is the second child, and her two brothers are healthy.  
A marfanoid mental retardation syndrome (OMIM 248770) was suspected at 26 years old because of a 
'typically' flat face and other marfanoid body habitus. Before the age of 2 years, she presented a developmental 
delay and dysmorphism that consisted of malar hypoplasia, a narrow and arched palate, micrognathia, long 
face, high forehead, anteverted nares, thick lip, large palpebral fissures, hollowed-out cheeks, arachnodactyly 
and little subcutaneous fat (Figure 1). An optic atrophy was also observed but not confirmed afterward. She was 
first treated by corticoids, but in the absence of improvement, she was treated by Rivotril. However, 
psychomotor difficulties were then amplified. In addition, she had an epicanthus and axial hypotonia, and her 
limbs were hypertonic. At 3 years old, her height was 105 cm (+2DS), weight was 15 kg (+1DS) and head 
circumference was 48 cm (-1DS). At 4 years, she was able to sit alone, but she had severe communication 
difficulties (no language, shouting, laughing and crying without any reason). She was irritable and agitated. She 
still had a severe myopia without family history, a palpebral coloboma, and little subcutaneous fat associated 
with prominent muscles, in addition to joint hyperextensibility (hands, fingers and toes). At the age of 6 years, 
she was still unable to speak, walk, dress, eat or wash by herself. She had convulsive spasms every day. 
Between 7 and 12 years old, she could walk with assistance and grab objects. She had many infections and 
suffered from a scoliosis. At 20 years old, she was taking a combination of different sedatives. She suffered 
from spastic paraplegia and severe epilepsy.  
A history of convulsive encephalopathy and spasms in flexion with hypsarrhythmia was shown with an 
electroencephalogram (EEG) analysis, and these required several hospitalisations. Other medical evaluations 
consisted of brain and spinal cord magnetic resonance imaging and blood amino acid and urine organic acid 
chromatographies, which were normal. CDG (congenital disorder of glycosylation) syndrome analysis was 
negative. Radiography revealed a hypertrophy at the tuft of the phalanx of the finger.  
Seven years later, one of her brothers and his pregnant wife asked for genetic counselling. As no 
biological marker exists to confirm marfanoid mental retardation syndrome (OMIM 248770), an array-CGH 
was proposed to the propositi.  
Oligonucleotide microarray 
Chromosome analysis was performed on lymphocyte cultures using standard procedures with RHG 
banding.  
Array-CGH analyses were performed using an Agilent Human Genome CGH microarray 105K 
consisting of 105,000 probes (Agilent Technologies, Santa Clara, CA). Experiments were performed with 1300 
ng of DNA following the instructions provided by Agilent (Agilent Oligonucleotide Array-Based CGH for 
Genomic DNA Analysis, v.5.0, June 2007). Arrays were analysed using the Agilent Scanner G2505B and 
Feature Extraction Software version 9.5.1. Copy number variations (CNV) were obtained using the CGH 
Analytics software v3.5.14 (ADM-1 algorithm; moving average window: 1 Mb; cut-off: 6; 3 consecutive 
probes for a positive call). 
Array-CGH validations  
QFM-PCR was carried out as previously described to validate and refine the size of the copy number 
variations found by array-CGH [14]. Targeted regions in and around the CNV (sequences may be obtained 
upon request) were amplified in a single PCR using the Qiagen Multiplex PCR kit (Qiagen, Courtaboeuf, 
France) and analysed on an ABI Prism 310 sequencer (Applied Biosystems, Foster City, California) with 
Genemapper v4 (Applied Biosystems). We used one control amplicon for sample normalisation and another on 
the X chromosome. Interpretation resulted in increased or decreased fluorescence for peaks in duplicated or 
deleted regions, respectively.  
Paternity testing was performed using the PowerPlex16® System kit following the protocol provided by 
Promega (Promega Corp., Madison, USA).  
Results 
Our patient had a normal karyotype (46,XX) as determined by conventional methods. The 105K array-
CGH experiment identified a 250 kb duplication in the 16q24.1 region, which includes 15 probes located 
between positions 84,263,921 and 84,500,230 bp (hg18) and encompasses seven genes (KIAA0182, GINS2, 
c16orf74, COX4NB, COX4I1, MIR1910 and IRF8). Other DNA gains and losses were also observed in the 
patient, but all of them were well-known copy number polymorphisms (CNP) 
(http://projects.tcag.ca/variation/). The QFM-PCR experiments, performed on the proband and her parents, 
showed that this duplication had arisen de novo and had refined breakpoint positions between approximately 
84,246,000 and 84,496,000 (Figure 2). No discordance was observed in the paternity testing (data not shown). 
In the DECIPHER database, we found three large deletions and one duplication that are responsible for various 
phenotypes, but no polymorphisms have been described in our region.  
Discussion 
Large duplications in the long arm of the chromosome 16 (16q11 → qter) that are not associated with 
other chromosomal gains or losses are very severe, causing malformations such as congenital cardiac defects, 
muscular hypotonia, failure to thrive and early death [5, 6]. 
 Because the phenotype of our case was less severe, we looked at 16q duplications that were closer to our 
region with breakpoints located between 16q21 and 16q24.3 [7, 9, 13]. When considering duplications with 5’ 
breakpoints located between 16q21 and 16q23, Houlston et al. [7] found similarities in patients facial features 
(a prominent forehead, midface hypoplasia and downward slant) and an association with intellectual disability, 
muscular hypotonia, congenital heart defects, failure to thrive, genitalia hypoplasia, periorbital edema, 
palpebral fissures and umbilical hernia [8-10]. Involvement of the 16q24 band causes similar characteristics, 
suggesting that some symptoms, such as developmental delay, cardiac defects, small palpebral fissures, 
periorbital edema, hypotonia, long fingers, recurrent infections, epicanthal folds broad/flat nasal bridge and 
high arched palate, may be related to the 16q24 → qter region [4, 11, 12]. As with many partial trisomies, 16q 
is associated with partial monosomy or trisomy, and the phenotypic effects of trisomy 16q may be influenced 
by secondary chromosome rearrangements; however, some trends tend to emerge. Table 1 summarises the most 
frequent clinical findings in patients with a duplicated segment of 16q.  
 Interestingly, three cases that were reported are phenotypically similar to our patient [4, 8, 10]. The first 
one was a t(16;22)(q24;q13.3) with a 22q deletion/16q duplication. The patient had a severe 
psychomotor/developmental delay with no speech, large nose and hyperextensibility of joints [8]. The other 
patients were carriers of a t(7;16)(p22.3;q24.1) with a 7p deletion/16q duplication and a 16q23.3 → qter 
duplication/5p15.32 → pter deletion, respectively [4, 10]. Among their features, they shared some 
characteristics with our patient: severe psychomotor retardation, hypotonia, long fingers, broad nasal bridge, 
high forehead, high-arched palate, epicanthal folds and malformed ears. Finally, sparse subcutaneous fat was 
also observed in patients with large duplications (5' breakpoints in 16q11, 16q13 or 16q21 bands), suggesting a 
possible involvement of the 16q24.1-qter region [7, 13]. Despite the fact that many cases have unbalanced 
translocations, which suggests a role for the autosomal monosomy associated with trisomy 16, these data 
suggest that the 16q24.1 region may contain several important genes associated with some features of the 
patient.  
 The duplicated region encompassed at least four genes that can be correlated with clinical features: 
IRF8, COX4NB, COX4I1 and MIR1910. IRF8 encodes “interferon regulatory factor 8.” Its functions are related 
to the immune response, which potentially explains the recurrent infections observed in patients [15].  Loss of 
function mutations in the IRF8 gene in mouse models are associated with susceptibility to infections and a 
chronic myeloid leukaemia-like syndrome [16]. Two genes belong to the cytochrome C oxidase subunit IV 
(COX4) family: COX4NB (COX4 neighbour) and COX4I1 (COX4 isoform 1). While the functions of the first 
gene are still unknown, the second gene appears to be implicated in different pathways. Among them, Kim et al. 
[17] found that the increased expression and translation of the COX4I1 gene may be associated with the 
lipoatrophy mechanism during antiretroviral treatment of human immunodeficiency virus (HIV) infection. This 
suggests a possible role for COX4I1 in the paucity of observed adipose tissue. Moreover, a non-synonymous G 
to A transition is associated with a reduction in cytochrome oxidase activity and could be associated with 
Alzheimer's disease [18]. Finally, the MIR1910 (microRNA 1910) gene encodes microRNAs that are involved 
in post-transcriptional regulation. This gene has not yet been implicated in intellectual disability, but the general 
misregulation of these small RNAs could contribute to abnormalities in brain development that are associated 
with psychomotor delays [19]. For example, a relationship between miRNA and DiGeorge syndrome has been 
suggested by Stark et al., who showed that a disruption of DGCR8 (DiGeorge critical region) is associated with 
a reduction in mature miRNAs in mouse brains, which leads to a deficit in cognitive performance [20]. An 
understanding of the role of non-coding RNAs in brain development would be important to identify disease-
coding genes and understand the biological pathways involved in the pathogenesis of intellectual disability.  
Due to the small size of the duplication presented here, this work may help to elucidate a critical region 
of the 16q chromosome associated with severe neurological and dysmorphic features. This duplication may 
cause alterations via different mechanisms: through a dosage effect of the genes located in the region, by 
disrupting genes at breakpoints, through a positional effect on neighbouring or distant genes and by containing 
regulatory elements for genes located far away on the chromosome [21] or associated with other mutation(s) in 
gene(s) contained in the duplication [22] or elsewhere in the genome. The effects of the duplication could also 
be different, as this duplication is in-tandem in the same chromosome, with a mechanism possibly mediated by 
repeated sequences or insertions in a different chromosomal region. However, caution must be used when 
attributing all of the phenotypical features noted in our patient to the duplication because this duplication may 
also be a novel CNV, as haploinsufficiency seems to be more common and penetrant than triplosensitivity for 
severe developmental phenotypes [23]. To conclude, additional reports of small duplications of this 16q24.1 
band would help to refine the phenotype associated with this 16q24.1 band.  
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Legends  
Figure 1 Proband at 26 years old. [A,B] Note long face, large palpebral fissure, anteverted nares, small and 
attached lobe and thick lips. [C,D] Long and thin fingers and stiffness of the wrist/hand. [E,F] Talipes 
equinovarus deformity and stiffness of the feet.  
Figure 2 Comparison of breakpoint characterisation by Array-CGH and QFM-PCR. Genomic positions are 
given through the hg18.  
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Our patient 
16q trisomic region 16q22-qter 16q21-? 16q23-? 16q24-? 16q23-qter 16q23.3-qter 16q23-qter 16q24.1-qter 16q24.1-qter 16q24.1 
Associated subtelomeric 
rearrangement 
15q- 10q- 3p- 22q- small 13p- 5p- 5q- 5q- 7p- 11q- 11q-  
De Novo 16q+ x       x x   x 
Intellectual disabilities     x ? x moderate language severe x x severe 
Head circumference <3
rd
 centile  31 cm 50
th




 44.5 cm   x 
Height  25-50
th





48.5 cm short   
Craniofacial dysmorphic features x x x x x x x x x   x 
High forehead x x   x x x  x x  x 
Broad nasal bridge  x  x x x   x x  x 
Long or short philtrum - x      x - x   
Micrognathia  x x   - -       
Ears malformed - x x x - x   x -  x 
Epicanthus      -  x x -  x 
Palpebral fissures  x    x -  x x x   
Thin lip(s)      x x  -   x 
Downward slant x           x 
Arched palate x     x   x x  x 
Other dysmorphic features  x      x    x 
Genitalia abnormalities - x    x   x x   
Fingers or feet features x    x x  x x x x x 
Hypotonia -    x x   x x  x 
Malformations   x x  - x  x x x x  
Recurrent infections          x x x 
Early death  x x          
 
Table 1 Summary of the clinical features of patients with partial trisomy 16q. Clinical features are present (x) or not present (-).
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